Uzbekistan and AstraZeneca Explore Bilateral Collaboration in Pharmaceutical Sector
Uzbekistan discusses pharmaceutical collaboration with AstraZeneca to boost local production and investment.


Ravshan Usmanov, Uzbekistan's Extraordinary and
Plenipotentiary Ambassador to the UK, met with Nitin Kapoor, AstraZeneca's
Deputy Head of Production Expansion, to talk about potential bilateral
collaboration. Kapoor gave a summary of AstraZeneca's worldwide operations and
research projects with the goal of creating ground-breaking cures for
significant illnesses. Usmanov talked about the changes being made to the
pharmaceutical industry in Uzbekistan in an effort to increase domestic
production capacity and draw in international investment.
Benefits for foreign investors include the opportunity to
commission new production facilities and a hospitable business climate. These
factors are anticipated to foster an environment that will facilitate
AstraZeneca's further expansion in the nation. The discussion ended with a
mutual commitment to further develop bilateral ties through visits and meetings
in the future, indicating a promising partnership between AstraZeneca and
Uzbekistan.

My international experience as a researcher in Taiwan for three years has equipped me with a global perspective, enabling me to create content that resonates with an international audience.
More from Pharma News
All stories →
Emcure Pharma Reports 23% Revenue Rise to Rs 2,580 Crore in Q1 FY2026

FDA CBER OTP Convenes Town Hall on CMC Readiness Standards for Gene Therapy BLA Submissions

Discussion